HOPKINTON, Mass., Feb. 6 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. today announced that its presentation at the BIO CEO & Investor Conference will be webcast on Monday, February 12, 2007 at 2:45 p.m. EST. Kevin Hrusovsky, President and CEO of Caliper, will be presenting. The live webcast can be accessed at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=CALP&item_id=1466858 An archived presentation will be available for 90 days.
Mr. Hrusovsky will also present at the Deutsche Bank Small Cap Growth Conference on Wednesday, February 14, 2006 at 10:40 a.m. The live webcast can be accessed at http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=CALP&item_id=1463895. An archived presentation will be available for 90 days.
About Caliper Life Sciences
Caliper Life Sciences is a leading provider of drug discovery and life sciences research solutions for the pharmaceutical and biotechnology industries. With its acquisitions of NovaScreen Biosciences and Xenogen Corporation, Caliper has positioned itself to transform drug discovery and development through a keen focus on clinically relevant experimentation. Caliper’s products and services, assembled from a leading portfolio of microfluidics, liquid handling, and imaging technologies, span in vitro and in vivo experimentation and address key issues on the critical path of drug discovery and development. More information about Caliper can be found at www.caliperLS.com.
Caliper Life Sciences, Inc.
CONTACT: Seth Lewis of The Trout Group, +1-781-420-2361, orslewis@troutgroup.com
Web site: http://www.caliperLS.com//
